In the fourth of a series of real asset investment case studies, Iryna Hanbury, Portfolio Manager at Gravis Capital Management, looks at hospitals.

As the UK’s healthcare system continues to grapple with rising demand, ageing populations, and strained acute care services, the need to bolster non-acute healthcare infrastructure has increased. From community clinics and rehabilitation centres to mental health facilities and social care services, these often-overlooked elements of the health system play a crucial role in maintaining wellbeing and preventing hospital admissions. Investing in this infrastructure is not only essential for easing pressure on NHS hospitals but also for delivering more holistic, accessible, and cost-effective care to communities across the country.

8.4%* of GCP Infrastructure Investments’ portfolio is currently invested in healthcare assets like this across England and Scotland.

GCP Infrastructure Investments Limited issued a loan note secured against subordinated debt in the Queen Elizabeth II (‘QEII’) Hospital in Welwyn Garden City, and six Local Improvement Finance Trust (“LIFT”) projects in the South East and Midlands. The primary counterparty for each project was the local Primary Care Trust (“PCT”). PCTs are statutory NHS bodies responsible for the delivery of health services. The LIFT assets are underpinned via a head lease with Community Health Partnerships (“CHP”), a Department of Health and Social Care owned company.

The QEII hospital in Welwyn Garden City is the largest asset, a day hospital that opened in 2015 replacing the original Queen Elizabeth hospital that opened in 1963. It provides a range of outpatient clinics and services including blood tests, as well as an urgent treatment centre which is open every day.

The hospital was designed to be sustainable and environmentally friendly; the shape and layout of the building creates natural shading, the window glass prevents the building from getting too hot and a planted green roof encourages biodiversity.

The underlying loan is financed from the subordinated cash flows that arise from the projects, with the investment returning an IRR of 7.7%. The loan allows the Company to earn an attractive yield from a portfolio of mature, well‑performing PPP/PFI projects that benefit from Government‑backed cash flows without taking equity risk, and therefore fits the Company’s investment strategy.

The nature of the underlying projects (non‑acute healthcare services) is at the stable and secure end of the infrastructure spectrum of asset types.

The UK was an early pioneer of PPPs, but following some criticism that earlier models were too complex and inflexible, the government has not deployed them since 2018. They could, however, make a limited come back. The UK 10-year Infrastructure Strategy, which was published in late June, made mention of a ‘careful and targeted’ return of PPP.

The report acknowledged that a significant increase in private investment is needed to complement and maximise the value of the extensive public investment underway and, as part of its incentives, would “explore the feasibility of using new PPP models for taxpayer-funded projects (for example in decarbonising the public sector estate and in certain types of primary care and community health infrastructure) in very limited circumstances where they could represent value for money.”

Read case study #5: social housing here.

*Source: Gravis, 31 March 2025

Important Information

This article has been prepared by Gravis Capital Management Limited (the "Investment Adviser“ or “Gravis”) and is for information purposes only. It is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to local law or regulation. Any recipients of this article outside the UK should inform themselves of and observe any applicable legal or regulatory requirements in their jurisdiction and are treated as having represented that they are able to receive this article without contravention of any law or regulation in the jurisdiction in which they reside or conduct business.

This article should not be considered as a recommendation, invitation or inducement that any investor should subscribe for, dispose of or purchase any such securities or enter into any other transaction in the GCP Infrastructure Investments Ltd (the “Company”) or any other fund affiliated with Gravis.  The merits and suitability of any investment action in relation to securities should be considered carefully and involve, among other things, an assessment of the legal, tax, accounting, regulatory, financial, credit and other related aspects of such securities.

No undertaking, representation, warranty or other assurance, express or implied, is made or given by or on behalf of the Company, the Investment Adviser or any of their respective directors, officers, partners, employees, agents or advisers or any other person as to the accuracy or completeness of the information or opinions contained in this article and no responsibility or liability is accepted by any of them for any such information or opinions or for any errors, omissions, misstatements, negligence or otherwise for any other communication written or otherwise. In addition, neither the Company or the Investment Adviser undertake any obligation to update or to correct any inaccuracies which may become apparent. The information in this article is subject to updating, completion, revision, further verification and amendment without notice.

Past performance is no guarantee of future performance.

Gravis Capital Management Ltd is authorised and regulated by the Financial Conduct Authority; registered in England and Wales No: 10471852 and its principal place of business is 24 Savile Row, London W1S 2ES.